Clearwater Analytics acquires Enfusion for $1.5 billion, enhancing portfolio management and SaaS revenue growth. Click here ...

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, ...

Enfusion, Inc. ENFN shares rallied 5% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Enfusion, Inc. (NYSE: ENFN)’s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in ...

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

ENFN) reported $49.46 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 15.8%. EPS of $0.05 for the same period compares to $0.04 a year ago.

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share ...